Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19835 | 26316434 | J Clin Res Pediatr Endocrinol | Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19836 | 26316333 | Sci Rep | GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance. | 2015 | Details |
| A19837 | 26315844 | Int J Obes (Lond) | Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment. | 2015 | Details |
| A19838 | 26315841 | Int J Obes (Lond) | Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK. | 2015 | Details |
| A19839 | 26315777 | Ann Nutr Metab | Association between Serum Sialic Acid Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. | 2015 | Details |
| A19840 | 26315331 | Diabet Med | Diabetic hepatosclerosis: another diabetes microvascular complication? | 2016 | Details |
| A19841 | 26315048 | J Lipid Res | Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway. | 2015 | Details |
| A19842 | 26314837 | J Gastroenterol | Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. | 2015 | Details |
| A19843 | 26314479 | Eur Radiol | Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. | 2015 | Details |
| A19844 | 26313307 | Hepatology | Physical activity and liver diseases. | 2015 | Details |
| A19845 | 26312773 | J Gastroenterol Hepatol | Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment. | 2016 | Details |
| A19846 | 26311412 | Hepatobiliary Surg Nutr | Retinoid roles in blocking hepatocellular carcinoma. | 2015 | Details |
| A19847 | 26311355 | Virchows Arch | β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study. | 2015 | Details |
| A19848 | 26310987 | Int J Cardiol | Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. | 2015 | Details |
| A19849 | 28943619 | Diseases | MOGAT2: A New Therapeutic Target for Metabolic Syndrome. | 2015 | Details |
| A19850 | 26308292 | J Clin Endocrinol Metab | Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. | 2015 | Details |
| A19851 | 26307979 | Int J Mol Sci | Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link? | 2015 | Details |
| A19852 | 26305052 | Biochem Cell Biol | Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. | 2015 | Details |
| A19853 | 26304302 | Aliment Pharmacol Ther | Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. | 2015 | Details |
| A19854 | 26303333 | Toxicology | Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes. | 2015 | Details |
| A19855 | 26303223 | Prim Care Diabetes | Analysis of the Japanese Diabetes Risk Score and fatty liver markers for incident diabetes in a Japanese cohort. | 2015 | Details |
| A19856 | 26303130 | Am J Gastroenterol | Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography. | 2015 | Details |
| A19858 | 26302023 | Eur J Gastroenterol Hepatol | Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. | 2015 | Details |
| A19859 | 26300958 | Chin Med | Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model. | 2015 | Details |
| A19860 | 26300331 | J Nutr Biochem | Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. | 2015 | Details |
| A19861 | 26300318 | Mol Nutr Food Res | Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. | 2015 | Details |
| A19862 | 26299811 | Toxicology | Protein tyrosine phosphatase 1B (PTP1B): A key regulator and therapeutic target in liver diseases. | 2015 | Details |
| A19864 | 26299412 | Gastroenterology | Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study. | 2015 | Details |
| A19865 | 26298775 | Sleep Med | Evaluation of circulating markers of hepatic apoptosis and inflammation in obese children with and without obstructive sleep apnea. | 2015 | Details |
| A19867 | 26297911 | Biochem Pharmacol | A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | 2015 | Details |
| A19868 | 26297218 | J Diabetes Complications | An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. | 2015 | Details |
| A19870 | 26293833 | Eur J Intern Med | Increased circulating adiponectin in males with chronic HCV hepatitis. | 2015 | Details |
| A19871 | 26293807 | Sci Rep | Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease. | 2015 | Details |
| A19872 | 26292849 | Br J Pharmacol | Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes. | 2015 | Details |
| A19873 | 26291667 | Clin Gastroenterol Hepatol | Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. | 2015 | Details |
| A19875 | 26290633 | World J Gastroenterol | Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions. | 2015 | Details |
| A19876 | 26290284 | Front Med | Molecular mechanisms of fatty liver in obesity. | 2015 | Details |
| A19877 | 26289793 | Sci Rep | Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. | 2015 | Details |
| A19878 | 26289505 | Niger J Clin Pract | Nonalcoholic fatty liver disease: Synopsis of current developments. | 2016 | Details |
| A19879 | 26289421 | Int J Cancer | Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history. | 2015 | Details |
| A19880 | 26289101 | Expert Rev Gastroenterol Hepatol | The benefits of exercise for patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19881 | 26288848 | EBioMedicine | Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease. | 2015 | Details |
| A19883 | 26285328 | Vopr Kurortol Fizioter Lech Fiz Kult | [The effectiveness of the spa and health resort-based treatment with the application of Essentuki-type drinking mineral waters for the management of non-alcoholic fatty liver disease in the patients presenting with type 2 diabetes mellitus]. | 2015 | Details |
| A19884 | 26284975 | Biochem Biophys Res Commun | Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity. | 2015 | Details |
| A19885 | 26284591 | Clin Gastroenterol Hepatol | Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. | 2015 | Details |
| A19886 | 26283807 | Anc Sci Life | Efficacy of herbomineral compounds and pathya (Ayurvedic dietary regime and physical exercise) in the management of Yakṛt Roga (Non-alcoholic fatty liver disease). | 2015 | Details |
| A19887 | 26283505 | Eur J Nucl Med Mol Imaging | The role of active brown adipose tissue in human metabolism. | 2015 | Details |
| A19888 | 26282675 | Gut | MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. | 2015 | Details |
| A19889 | 26282529 | Proc Nutr Soc | Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice. | 2015 | Details |
| A19890 | 26281602 | Zhongguo Zhong Yao Za Zhi | [Intervention effect and mechanism of compound Ginkgo biloba preparations on nonalcoholic fatty liver]. | 2015 | Details |
| A19891 | 26281317 | Turk J Med Sci | Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH). | 2015 | Details |
| A19892 | 26281176 | Eksp Klin Gastroenterol | [ALLELES C282Y AND H63D HFE GENE, INSULIN RESISTANCE AND SUSCEPTIBILITY TO DISTURBANCE OF PORPHYRIN METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2015 | Details |
| A19893 | 26280342 | FP Essent | Metabolic Syndrome: Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19894 | 26278630 | Acta Clin Belg | A lady with NASH and choreoathetosis. | 2015 | Details |
| A19897 | 26278463 | Horm Res Paediatr | Risk for Nonalcoholic Fatty Liver Disease in Young Adults Born Preterm. | 2015 | Details |
| A19898 | 26278393 | Curr Mol Pharmacol | Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances. | 2017 | Details |
| A19899 | 26278387 | Curr Mol Pharmacol | Review: Precision Cut Liver Slices for the Evaluation of Fatty Liver and Fibrosis. | 2017 | Details |
| A19900 | 26278350 | Diabetes Res Clin Pract | Country of birth modifies the association of fatty liver index with insulin action in Middle Eastern immigrants to Sweden. | 2015 | Details |
| A19901 | 26276551 | BMC Endocr Disord | Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years. | 2015 | Details |
| A19902 | 26274335 | Hepatology | Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. | 2015 | Details |
| A19903 | 26273656 | Biomed Res Int | Fructose-Drinking Water Induced Nonalcoholic Fatty Liver Disease and Ultrastructural Alteration of Hepatocyte Mitochondria in Male Wistar Rat. | 2015 | Details |
| A19904 | 26273651 | Biomed Res Int | Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators. | 2015 | Details |
| A19905 | 26273621 | Biomed Res Int | Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis. | 2015 | Details |
| A19906 | 26273620 | Biomed Res Int | Improvement of BMI after Lifestyle Intervention Is Associated with Normalisation of Elevated ELF Score and Liver Stiffness in Obese Children. | 2015 | Details |
| A19907 | 26273604 | Biomed Res Int | The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19908 | 26273598 | Biomed Res Int | Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis. | 2015 | Details |
| A19909 | 26273591 | Biomed Res Int | Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease. | 2015 | Details |
| A19910 | 26272872 | J Hepatol | Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. | 2015 | Details |
| A19911 | 26272871 | J Hepatol | Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial. | 2015 | Details |
| A19912 | 26272032 | Bioorg Med Chem | Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure. | 2015 | Details |
| A19913 | 26271188 | Int J Obes (Lond) | Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. | 2015 | Details |
| A19914 | 26270641 | PLoS One | Low Serum Hepcidin in Patients with Autoimmune Liver Diseases. | 2015 | Details |
| A19915 | 26270240 | J Gastroenterol Hepatol | Acetylcholine induces fibrogenic effects via M2/M3 acetylcholine receptors in non-alcoholic steatohepatitis and in primary human hepatic stellate cells. | 2016 | Details |
| A19916 | 26269698 | Case Rep Gastroenterol | Glycogenic Hepatopathy: Thinking Outside the Box. | 2015 | Details |
| A19917 | 26269440 | Zhonghua Nei Ke Za Zhi | [The impact of non-alcoholic fatty liver disease on islet function in type 2 diabetes]. | 2015 | Details |
| A19918 | 26269425 | Sci Rep | Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort. | 2015 | Details |
| A19919 | 26265792 | Clin Sci (Lond) | Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. | 2015 | Details |
| A19920 | 26265520 | Arch Iran Med | PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol. | 2015 | Details |
| A19921 | 26264980 | J Endocrinol | Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity. | 2015 | Details |
| A19922 | 26264689 | Proc Nutr Soc | Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein. | 2015 | Details |
| A19923 | 26264356 | Liver Int | The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP). | 2015 | Details |
| A19924 | 26263022 | Sci Rep | Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis. | 2015 | Details |
| A19925 | 26262841 | J Agric Food Chem | Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development. | 2015 | Details |
| A19926 | 26261693 | World J Hepatol | Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review. | 2015 | Details |
| A19927 | 26260846 | Biochim Biophys Acta | 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism. | 2015 | Details |
| A19928 | 26260755 | Gut Liver | Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. | 2016 | Details |
| A19929 | 26259026 | Liver Int | TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. | 2015 | Details |
| A19930 | 26258810 | Eur J Cancer Prev | Pentoxifylline prevents nonalcoholic steatohepatitis-related liver pre-neoplasms by inhibiting hepatic inflammation and lipogenesis. | 2016 | Details |
| A19931 | 26256971 | Yonsei Med J | Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis. | 2015 | Details |
| A19932 | 26256903 | Ann Hepatol | Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4. | 2016 | Details |
| A19933 | 26256895 | Ann Hepatol | SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women. | 2016 | Details |
| A19934 | 26256740 | Lipids Health Dis | Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? | 2015 | Details |
| A19935 | 26256590 | Liver Int | Natural course of subjects with elevated liver tests and normal liver histology. | 2015 | Details |
| A19936 | 26256414 | Sci Rep | Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults. | 2015 | Details |
| A19937 | 26256085 | Hepatobiliary Pancreat Dis Int | Clinical characteristics and outcome of hepatocellular carcinoma in alcohol related and cryptogenic cirrhosis: a prospective study. | 2015 | Details |
| A19938 | 26255044 | Gastroenterology | Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. | 2015 | Details |
| A19939 | 26253086 | Clin Sci (Lond) | CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis. | 2015 | Details |
| A19940 | 26252921 | J Pediatr Gastroenterol Nutr | Physical Activity Is Prospectively Associated With Adolescent Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A19941 | 26252899 | PLoS One | Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. | 2015 | Details |
| A19942 | 26252777 | PLoS One | Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. | 2015 | Details |